Delineating a Clinical Problem: Asking the Right Question and Asking the Question Right Peter Wyer MD Associate Clinical Professor of Medicine Columbia University College of Physicians & Surgeons Chair, Section on Evidence Based Health Care, New York Academy of Medicine
21
Embed
Delineating a Clinical Problem: Asking the Right Question and Asking the Question Right
Delineating a Clinical Problem: Asking the Right Question and Asking the Question Right. Peter Wyer MD Associate Clinical Professor of Medicine Columbia University College of Physicians & Surgeons Chair, Section on Evidence Based Health Care, New York Academy of Medicine. - PowerPoint PPT Presentation
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Delineating a Clinical Problem: Asking the Right Question and Asking the Question Right
Peter Wyer MD Associate Clinical Professor of Medicine
Columbia University College of Physicians & SurgeonsChair, Section on Evidence Based Health Care, New York Academy of Medicine
The Concept of Clinical Action
Silva, J Eval Clin Pract. 2011;17:585
“Knowledge does notextend from thosewho consider theyknow to those whoconsider they do notknow. Knowledge isbuilt in therelationship betweenhuman beings andperfects it self in theCritical Problematization ofthese relations.”Paulo Freire
The Concept and Role of PACT
• 4 subdomains of clinical action always tacitly present within a problem together with other determinants of care
• PACT is a tool of representation that allows deconstruction of a problem into actionable components
• This facilitates meaningful identification and assimilation of research evidence into the solution
The SIMPLE Model
ValuesValues
PreferencesPreferences
PrioritiesPrioritiesProblem delineation
“The process of problematization implies a critical return to action. It starts from action and returns to it”
Paulo Freire, 1972
Problem delineation
“The process of problematization implies a critical return to action. It starts from action and returns to it”
Paulo Freire, 1972
P
Problem
AAction
CChoices
TTargets
Utility
Performance
Probability
Silva, Charon, Wyer. JECP 2010.
P
ati
ent-
Pra
ctit
ion
er R
ela
tio
nsh
ip a
nd
an
d P
ract
ice
Cir
cum
sta
nc
es
P
Problem
AAction
CChoices
TTargets
Utility Share consideration of the utility
Alternatives
Estimate of impact on patient outcomes
PerformanceShare
consideration of the
performance
Alternatives Estimate of effect of predictors
Probability Share
consideration of the
probability
---
Estimate of likelihood of possible outcomes
Silva, Charon, Wyer. JECP 2010.
P
ati
ent-
Pra
ctit
ion
er R
ela
tio
nsh
ip a
nd
an
d P
ract
ice
Cir
cum
sta
nc
es
The Anatomy of the QuestionThe Anatomy of the Question
opulation
ntervention
omparison
utcome
Why PICO—the 2-PICO Assessment for Directness
Example: a Patient with Atrial FibrillationUma mulher de 68 anos é trazida ao pronto-socorro por causa do início
súbito de palpitações e é encontrada em FA (fibrilação atrial) com freqüência ventricular de 140-160. Seus sinais vitais encontram-se dentro da normalidade e ela não apresenta congestão pulmonar, insuficiência respiratória, angústia ou outros. Sua família afirma que isso já aconteceu antes e "os medicamentos utilizados não funcionaram e eles tiveram de chocá-la." Ela tem história de hipertensão leve, mas não de doença cardíaca estrutural ou de outras comorbidades importantes. Sua família espera que ela possa ser tratada e liberada do Departamento de Emergência. As instalações hospitalares deste hospital habitualmente admitem esses pacientes. Os médicos plantonistas discutem sobre qual droga deve ser utilizada para tratamento e se devem priorizar controle de FC (frequência cardíaca) ou controle do ritmo.
P
Problem
AAction
CChoices
TTargets
UtilityUtility of pharmacological agents
Alternative drug choices
Estimate of impact on return to sinus rhythm, complications of AF
PerformancePerformance of CHADAS2 score
---Estimate of accuracy
Probability
Short term probability of embolic events after emergency cardioversion
Estimate of likelihood
Silva, Charon, Wyer. JECP 2010.
P
ati
ent-
Pra
ctit
ion
er R
ela
tio
nsh
ip a
nd
an
d P
ract
ice
Cir
cum
sta
nc
es
PP
II
CC
OO
TherapyTherapyUtilityUtility
PP
II
CC
OO
TherapyTherapyUtilityUtility
PPElderly patients with acute onset, stable, AF but no structural heart disease presenting to emergency departments within 48 hours of onset
II Rapid acting pharmacological agents safely titrated to effect
CC Alternative regimens safely titrated to effect
OOLikelihood of rate control or conversion, hospital admission rate, likelihood of complications of uncontrolled AF, adverse reactions to drugs
TherapyTherapyUtilityUtility
HarmHarmProbabilityProbability
PPElderly patients with acute onset, stable, AF but no structural heart disease presenting to emergency departments within 48 hours of onset
II Rapid acting pharmacological agents safely titrated to effect
CC Alternative regimens safely titrated to effect
OOLikelihood of rate control or conversion, hospital admission rate, likelihood of complications of uncontrolled AF, adverse reactions to drugs
TherapyTherapyUtilityUtility
HarmHarmProbabilityProbability
PPElderly patients with acute onset, stable, AF but no structural heart disease presenting to emergency departments within 48 hours of onset
Elderly patients with acute onset, stable, AF but no structural heart disease presenting to emergency departments within 48 hours of onset
II Rapid acting pharmacological agents safely titrated to effect
Cardioversion in ED with release and early follow up
CC Alternative regimens safely titrated to effect ----
OOLikelihood of rate control or conversion, hospital admission rate, likelihood of complications of uncontrolled AF, adverse reactions to drugs
Short term complications of cardioversion, embolic events, admission to hospital, other complications of AF.
Prognostic Prognostic PerformancePerformance
PPElderly patients with acute onset, stable, AF but no structural heart disease presenting to emergency departments within 48 hours of onset
IISpecific predictors of complications of AF or an organized prediction rule
CCNA
OOImpact of predictors or the prediction rule on likelihood of stroke, other embolic events, decompensated heart failure, MI
PP
II
CC
OO
PP
II
CC
OO
PP
II
CC
OO
SUMMARY• Scientifically informed, effective care, requires
“critical problematization” across all parties and dimensions
• The need for information is derived from the problem at all levels
• PICO allows connecting questions to research information and assessment of directness
• If the problem is wrong, the question is wrong; if the question is wrong, evidence based methods and resources are misguided